Navigation Links
IDIBELL license to Minoryx a patent of a product to treat a rare neurodegenerative disease
Date:5/7/2013

The Bellvittge Biomedical Research Institute (IDIBELL) has signed a licensing agreement with the Spanish biotechnology company Minoryx of a patent for the treatment of X-linked adrenoleukodystrophy, a rare serious neurodegenerative disease which has no effective treatment.

The Neurometabolic Diseases group led by ICREA researcher Aurora Pujol, has developed an animal model to study this disease. Studies using this model have shown that the patented product, a repositioned drug, may be effective against X-linked adrenoleukodystrophy.

The obtaining of the patent and the license has been managed by the Technology Transfer Office of IDIBELL. The license represents an opportunity not only to get this invention into the market and patients, but also to initiate a partnership of trust between the company and IDIBELL in developing new solutions to improve the quality of life of patients with adrenoleukodystrophy.

Hereditary disease

The X-linked adrenoleukodystrophy is an inherited disease that destroys the myelin (white matter that coats the nerves) at the central or peripheral nervous system and causes hormonal changes. Patients have a genetic mutation that impedes the properly degradation of very long chain fatty acids within cells. This causes the accumulation of this type of fat in plasma and tissues, especially in the brain and adrenal gland, causing irreversible damage.

This is a rare disease that affects only male subjects, although female carriers may also experience some symptoms. Its incidence is one case per 17,000 men. It is the most common type of leukodystrophy and the main peroxisome disorder. The peroxisome is the part of the cell responsible for eliminating toxic products. The disease became famous in 1992 with the film Lorenzo's oil, starring by Nick Nolte and Susan Sarandon.

Pioglitazone acts on the nuclear receptor PPAR-gamma and to a lesser extent, on PPAR-alpha. These are proteins that regulate the storage of fatty acids and the glucose metabolism and also enhance peroxisome proliferation in cells.

More studies

The drug has been successful in animal experiments, but more studies will be needed before the product can be applied to X-linked adrenoleukodystrophy patients. In this sense, the signing of the license agreement with Minoryx is an important step to use the drug for this purpose in the future.


'/>"/>

Contact: Arantxa Mena
comunicacio@idibell.cat
34-932-607-129
IDIBELL-Bellvitge Biomedical Research Institute
Source:Eurekalert

Related medicine news :

1. Coding Certiifcation.Org Under License With the AAPC, Adds Certified Physician Practice Manager to their Product Course Offerings
2. Cosmetic Surgery – Protecting Consumers from Unlicensed Practitioners
3. Dr. Stephen Lazarus Continues to Recognize the Importance of Quality, Medical Skin Care and Products in Welcoming Licensed Paramedical Esthetician, Amye Smith
4. CodingCertification.Org (CCO) Enters a License Agreement With the AAPC to Add the Professional Medical Coding Curriculum (PMCC) to its Course Offerings
5. EverCheck: Healthcare, Human Resources, & License Verification
6. Bridges to Recovery Reaches Ten-Year Milestone as Premiere, Licensed Residential Behavioral Treatment Program and Honors Founding Medical Director Dr. Terry V. Eagan
7. University of Minnesota licenses Clinical Decision Support technology
8. Patent Issued for Apparel and Textile Fabric with Antimicrobial Properties
9. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
10. Human Gene Patent Case Goes to Supreme Court
11. A New Alarm Clock App (Patent Pending) Helps to Lose Weight and Fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... BC (PRWEB) , ... April 25, 2017 , ... The ... from Richmond, BC, who live with dental fear and require sedation to receive dental ... at ease during various procedures, from hygienic cleanings to oral surgery, at their ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America ... with a reputable physician in their area, announces the launch of a new and ... patients who are looking for reputable physicians to help them with back or neck ...
(Date:4/25/2017)... ... ... There is no better place in South Florida to undergo two common ... issue of Consumer Reports focused on heart health. , The magazine gave ... coronary bypass and aortic valve replacement procedures. , Consumer Reports rated Memorial’s ...
(Date:4/24/2017)... ... ... Michael Vick announced his retirement earlier this year from the NFL after thirteen ... in the 2001 NFL Draft, to the Atlanta Falcons, made four Pro Bowl appearances ... yards by a quarterback (6,109) and the most rushing yards by a quarterback in ...
(Date:4/24/2017)... San Antonio, TX (PRWEB) , ... April 24, 2017 , ... ... sky-high by the glitterati, those unreal icons inhabiting the rarified air of pop and ... by the paparazzi and anyone snapping pictures: the smile. Grins now run the gamut ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research ... America Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, ... Segment Forecasts, 2014 - 2025" report to their offering. ... The Latin American ... 21.0 billion by 2025 Low drug registration cost ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 ... Surgical drainage devices are tubes used to remove excess ... include, blood, serum, pus, urine, bile or lymph. Surgical ... types of surgery such as orthopedics surgery, cardiovascular surgery, ... device is prophylactic post-surgery to prevent accumulation of fluid ...
(Date:4/19/2017)... April 19, 2017 ... immune response in pets such as canine, avian ... of various types such as Attenuated Live Vaccines, ... DNA Vaccines and Recombinant Vaccines. Attenuated live vaccines ... or bacteria, which have been weakend under laboratory ...
Breaking Medicine Technology: